View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters

Relationship Between Sleep, Tau, and Race in Preclinical Alzheimer disease

Anthony Briggs, Ph.D.
New York, NY - United States
2024

Fostering Equitable Dementia Care for Hispanic/Latino Communities

Sara Bybee, Ph.D.
Salt Lake City, UT - United States
2024

Epidemiology and deep phenotyping of Argentinian patients with tauopathies

Blas Couto, Ph.D.
Buenos Aires, Argentina
2024

Genetic and environmental contributions to longitudinal tau trajectories

Anouk den Baraber, Ph.D.
Amsterdam, Netherlands
2024

Understanding the Negative Impact of APOE4 on Neural Responses to Estrogens

Karyn Frick, Ph.D.
Milwaukee, WI - United States
2024

Targeting Polyglutamylated Tubulin as an Early Treatment Strategy for AD

Torben Hausrat, Ph.D.
Hamburg, Germany
2024

Ventral Hippocampal Circuitry Underlying Neuropsychiatric Symptoms in AD

Holly Hunsberger, Ph.D.
North Chicago, IL - United States
2024

Replacement of Peripheral APOE4 with APOE2: Effects on AD Pathology

Lance Johnson, Ph.D.
Lexington, KY - United States
2024

Identifying the Mechanisms that Underlie Tau Aggregation and Neurotoxicity

Sarah Kaufman, M.D., Ph.D.
San Francisco, CA - United States
2024

PET imaging of neuroinflammation in dementia with Lewy bodies

Min-Jeong Kim, M.D., Ph.D.
Stony Brook, NY - United States
2024

Socioemotional mechanisms underlying social vulnerability in dementia

Jayden Lee, Ph.D.
Nashville, TN - United States
2024

Remote Sensing for ADRD-Specific Activities Identification in Older Adults

Knoo Lee, Ph.D.
Columbia, MO - United States
2024

Biological Aging Underlies Neurodegeneration Across the Adult Lifespan

Dan Liu, Ph.D.
Bonn, Germany
2024

Targeting late-life depression to mitigate Alzheimer's dementia

Victor Luna, Ph.D.
Philadelphia, PA - United States
2024

APOE Modifiers of Human Microglia Biology in Alzheimer’s disease

Renzo Mancuso, Ph.D.
Ghent, Belgium
2024

Studies of MOAG-4/SERF-2 as a link between obesity and Alzheimer's disease

Eyleen O'Rourke, Ph.D.
Charlottesville, VA - United States
2024

Lithiated gold nanoparticles as promising therapy for Alzheimer's disease

Roberto Piacentini, Ph.D.
Milan, Italy
2024

Harmonization of Tau PET Tracers to a Common Scale Using Head-to-Head Data

Guilherme Povala, Ph.D.
Pittsburgh, PA - United States
2024

Biological validation of MBI as part of the ADRD spectrum

Natalia Rocha, Ph.D.
Houston, TX - United States
2024

Supplement to Novel mouse models to study the biology of APOE variant risk

Michael Sasner, Ph.D.
Bar Harbor, ME - United States
2024

Identification of Modifiers of APOEe4 Toxicity

Beth Stevens, Ph.D.
Boston, MA - United States
2024

Emulating Early Physical Activity and Multidomain Interventions on ADRD

Jingkai Wei, Ph.D.
Columbia, SC - United States
2024

Primary Care-Based Screening Pathway and Care Bundle for Persons with Early Cognitive Impairment Using an EHR Algorithm, Remote Clinical Assessment, and Blood Biomarkers

Jeff Williamson
Winston-Salem, NC - United States
2024

Development of chemical exchange saturation transfer MRI for dementia with Lewy bodies

Phillip Zhe Sun, Ph.D.
Altanta, GA - United States
2024

Uncovering miRNA-mediated Adipose-Brain Crosstalk in Alzheimer’s Disease

Marcelo A. Mori, Ph.D.
Campinas, Brazil
2023

Association Between Longitudinal Changes in Plasma GFAP and AD Progression

Sarah Abbas, Ph.D.
Pittsburgh, PA - United States
2023

Vascular cognitive impairment in diabetes: mechanisms and intervention

Kareem Abdelsaid, Ph.D.
Charleston, SC - United States
2023

Identifying ethnic disparities in AD risk and blood biomarkers in Israel

Maison Abu Raya, M.D.
Haifa, Israel
2023

Inclusive ADRD Clinical Trials: Screening, Enrolling Latino Participants

G. Adriana Perez, Ph.D.
Philadelphia, PA - United States
2023

Identification of retromer modifiers by arrayed genome-wide perturbation

Adriano Aguzzi, M.D.
Zurich, Switzerland
2023

1 2 3 4 5 6 7 8 9 10... >|